Method for treating connective tissue disorders
November 16, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesEndodontic composition and method Nonstress-bearing implantable bone prosthesis Biodegradable porous ceramic delivery system for bone morphogenetic protein Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites Sputtered indium oxide films Technique for healing lesions in cartilage Compositions and methods for repair of cartilage and bone Unique bone regeneration tricalcium phosphate Osteoprosthetic implant Patent #: 5061286 InventorsApplicationNo. 614912 filed on 11/16/1990US Classes:435/325, ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE424/93.7, Animal or plant cell424/93.71, Leukocyte424/549, Skeleton (e.g., bone, teeth, etc.)424/577, Hemic or immune system (e.g., hematopoietic system, bone marrow cells, etc.)530/838, Marrow; spleen530/840, Bones; tendons; teeth; cartilage623/919, Bone623/920METHOD OR APPARATUS FOR PREPARING OR TREATING PROSTHETICExaminersPrimary: Green, Randall L.Assistant: Brittingham, Debra S. Attorney, Agent or FirmInternational ClassesA61F 002/28A61K 035/12 AbstractThe present invention is directed to various processes and devices for utilizing isolated and culturally expanded marrow-derived mesenchymal cells (i.e. mesenchymal stem cells) for treating skeletal and other connective tissue disorders. |
| ||||||||||||||
